Delivery Order SPE2DB22D3501-SPE2DB23FWG74
Award Date 7/6/23
Potential Completion Date 7/7/23
Potential Value $1.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $178,140 firm fixed price delivery order to AmerisourceBergen Drug Corporation for Lantus SoloSTAR insulin injection devices. Under this order, AmerisourceBergen will deliver 100 units per milliliter Lantus SoloSTAR pens in 3 milliliter cartridges to a facility in Conshohocken, Pennsylvania by June 27, 2023 in support of the Department of Defense's medical supply needs. As a top tier subcontractor to various DLA indefinite delivery/indefinite quantity...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,378 to Amerisourcebergen Drug Corporation for Lantus SoloStar insulin injection devices. As the prime contractor, Amerisourcebergen will supply 100 units per milliliter Lantus SoloStar in 3 milliliter cartridges to support the Defense Logistics Agency's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in early August...
- The Defense Logistics Agency awarded a delivery order valued at approximately $1,188 to Amerisourcebergen Drug Corporation for the supply of Lantus SoloStar insulin injection devices. As the prime contractor, Amerisourcebergen will provide 100 units per milliliter of the drug in 3 milliliter cartridges to support DLA's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period from August 7-8, 2023. The firm fixed price...
- The Defense Logistics Agency awarded a $356 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of Lantus SoloStar insulin injection devices. Under this order, Amerisourcebergen will deliver 100 units/mL 3mL vials of Lantus insulin to a location in Conshohocken, Pennsylvania by July 26, 2023 in support of the Department of Defense's medical supply needs. As a top tier subcontractor to various DLA indefinite delivery/indefinite quantity contracts,...
- The Defense Logistics Agency awarded a $2,038.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 3mL Lantus SoloStar insulin injection devices. The contract has a period of performance from July 25, 2023 through July 26, 2023, with performance taking place in Conshohocken, Pennsylvania. As a major supplier of pharmaceuticals and medical supplies, Amerisourcebergen will deliver the contracted insulin devices to support the DLA's provision of medical...
- The Defense Logistics Agency awarded a $5,700 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of Lantus SoloStar insulin injection devices. As the prime contractor, Amerisourcebergen will deliver 100 units per milliliter 3 milliliter Lantus SoloStar pens to support DLA medical readiness programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania by September 14, 2023. The delivery order was issued under DLA's pharmaceuticals...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,078 to Amerisourcebergen Drug Corporation for the supply of Lantus SoloStar insulin injection devices. The order is for 100 units per milliliter in 3 milliliter cartridges and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by July 26, 2023 in support of DLA's medical supply procurement programs. No set-aside designations or subcontractors were identified for this...
- The Defense Logistics Agency awarded Amerisourcebergen Drug Corporation a firm fixed price delivery order valued at approximately $540 to supply Lantus SoloStar insulin injection devices. Under the terms of the award, Amerisourcebergen will deliver 100 units per milliliter Lantus SoloStar 3mL cartridges to a facility in Conshohocken, Pennsylvania by August 24, 2023. The ordering agency, DLA, manages the procurement of medical supplies and equipment for the U.S. Department of Defense and this...
- The Defense Logistics Agency awarded a $1,219 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of Lantus SoloStar insulin injection devices. Under this order, Amerisourcebergen will deliver 100 units per milliliter Lantus SoloStar in 3 milliliter cartridges to a location in Conshohocken, Pennsylvania by July 26, 2023. The Defense Logistics Agency manages the Department of Defense's global supply chain and is responsible for procuring medical supplies and...
- The Defense Logistics Agency awarded a $178,140 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 3mL Lantus SoloStar 100 unit/ml insulin injection devices. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, Amerisourcebergen will deliver the contracted products from its facility in Conshohocken, Pennsylvania to fulfill DLA requirements between August 17-18, 2023. No set aside designation or subcontracting details...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB23FWG74Delivery Order
The Defense Logistics Agency awarded a $1,643 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of Lantus SoloStar insulin injection devices. The order is for 100 units per milliliter in 3 milliliter cartridges and will be fulfilled from Amerisourcebergen's facility in Conshohocken, Pennsylvania by July 7, 2023 to support the Department of Defense's medical supply needs. As a top tier provider on the DLA's Pharmaceutical Prime Vendor contract, Amerisourcebergen will deliver the contracted insulin products without a specific small business set-aside designation.
Generated 12/24/23, 12:12 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 7/6/23 |